What is INSM's current stock price?

As of now, INSM is trading at $174.09, with a daily change of -1.28%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

INSM Stock Analysis & IQ Rating | Insmed

INSM

Insmed

$174.09

-$2.25 | -1.28%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$212.75

MKT CAP

$37.13B

52W Low

$60.4

VOL

$1.63M

P/E Ratio

N/A

AVG VOL

$3.67M

RSI

37.65

TREND

Sideways

BQ Stock IQ

Login to see Insmed (INSM) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

INSM Target Price

Login to display

Strengths

INSM Rewards

Upgraded on attractively valued

INSM Rewards

Earnings are forecast to grow

INSM Rewards

Outperform the market

INSM Rewards

Investors confidence is positive

INSM Price Performance

$206.78 (-15.81%)

$158.28 (+9.99%)

$109.55 (+58.91%)

$72.75 (+139.30%)

1year

6month

3month

1month

INSM Risk Level

INSM has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Fair

LOW

HIGH

INSM Analysts Opinion

INSM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

INSM Analysts Opinion

INSM Analysts opinion is positive and also has improved from the past 3 months

INSM Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

60%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

13%

75%

INSM Street Sentiment

INSM Street Sentiment is bullish and have positive views on the near-term outlook

INSM Performance Sentiment

Sentiments overview associated with INSM events and the stock performance.

60%

32%

Positive

Negative

15 out of 25
events present

8 out of 25
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$174.09

Resistance
Price

$159.93

Current Price Range

$206.78

Show methods +

Linked to INSM

IQ

Close Price

Change

SNY

3.80

48.74

+0.81%

XOMA

2.13

26.18

+3.68%

REGN

4.21

773.94

-0.84%

MRK

4.20

106.06

-0.53%

MLTX

3.50

13.21

-3.54%

INSM Latest Analysis +

A Closer Look at Insmeds Options Market Dynamics. High-rolling investors have positioned themselves bearish on Insmed (NASDAQ:INSM) and it'.s important for retail traders to take note.\This activity came to our attention today through Benzinga'.s tracking of publicly available options data. The identities of these investors are uncertain but such a significant move in INSM often signals that someone has privileged information.Today Benzinga'.s options scanner spotted 8 options trades

Fri Dec 26, 2025

$177.88 | +0.26%

Momentum

Potential

HC Wainwright & Co. Maintains Insmed (INSM) Buy Recommendation. Fintel reports that on December 18 2025 HC Wainwright &. Co. maintained coverage of Insmed (NasdaqGS:INSM) with a Buy recommendation. Analyst Price Forecast Suggests 30.50% Upside

Fri Dec 19, 2025

$174.84 | +4.98%

Rating

Goldman Sachs Maintains Insmed (INSM) Buy Recommendation. Fintel reports that on December 18 2025 Goldman Sachs maintained coverage of Insmed (NasdaqGS:INSM) with a Buy recommendation. Analyst Price Forecast Suggests 30.50% Upside

Fri Dec 19, 2025

$174.84 | +4.98%

Rating

TD Cowen Maintains Insmed (INSM) Buy Recommendation. Fintel reports that on December 18 2025 TD Cowen maintained coverage of Insmed (NasdaqGS:INSM) with a Buy recommendation. Analyst Price Forecast Suggests 30.50% Upside

Fri Dec 19, 2025

$174.84 | +4.98%

Rating

RBC Capital Maintains Insmed (INSM) Outperform Recommendation. Fintel reports that on December 18 2025 RBC Capital maintained coverage of Insmed (NasdaqGS:INSM) with a Outperform recommendation. Analyst Price Forecast Suggests 30.50% Upside

Fri Dec 19, 2025

$174.84 | +4.98%

Potential

Rating

Guggenheim Maintains Insmed (INSM) Buy Recommendation. Fintel reports that on December 18 2025 Guggenheim maintained coverage of Insmed (NasdaqGS:INSM) with a Buy recommendation. Analyst Price Forecast Suggests 30.50% Upside

Fri Dec 19, 2025

$174.84 | +4.98%

Rating

Noteworthy Thursday Option Activity: INSM MDB HEI. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Insmed Inc (Symbol: INSM) where a total volume of 13421 contracts has been traded thus far today a contract volume which is representative of approximately 1.

Thu Dec 18, 2025

$166.55 | -16.08%

Momentum

Why Is Insmed Stock Falling Thursday?. INSM) stock plunged on Thursday.The company released data from the Phase 2b BiRCh study of brensocatib in patients with chronic rhinosinusitis .The trial did not meet its primary or secondary efficacy endpoints in either the 10 mg or .Brensocatib was well tolerated with no new safety signals identified including in the 40 mg arm which is the highest dose Insmed has studied to date.Insmed has discontinued its development program of brensocatib in CRSsNP effe

Thu Dec 18, 2025

$166.55 | -16.08%

Momentum

Insmed is Now Oversold (INSM). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

Thu Dec 18, 2025

$166.55 | -16.08%

Technical

INSM Stock Plummets on Sinus Study Failure Adds New Pipeline Asset. Insmed sinks nearly 20% after Brinsupri failed a phase IIb sinus study while the company adds a new monoclonal antibody asset to expand its pipeline.

Thu Dec 18, 2025

$166.55 | -16.08%

Activity

FAQ About INSM Stock Insights

What is INSM current stock price?

What are INSM stock strengths?

What is INSM Risk Level?

What is INSM market cap and volume?

What is INSM current Stock IQ?

Should I buy INSM stock right now?

Is INSM a Strong Buy right now?

What does a 'Strong Buy' rating mean for INSM?

What does a 'Strong Sell' rating mean for INSM?

What factors influence INSM's Stock IQ?

Explore our INSM Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored INSM Stock Strategies
Effective Risk Management

FIND US ON

Receive our INSM Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

INSM

Insmed

Current Price

$174.09

-$2.25 | -1.28%

52W High

$212.75

MKT CAP

$37.13B

52W Low

$60.4

VOL

$1.63M

P/E Ratio

N/A

AVG VOL

$3.67M

RSI

37.65

TREND

Sideways

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

INSM Rewards

Upgraded on attractively valued

INSM Rewards

Earnings are forecast to grow

INSM Rewards

Outperform the market

INSM Rewards

Investors confidence is positive

Linked to INSM

Symbol

IQ

Close

Change

SNY

3.80

48.74

+0.81%

XOMA

2.13

26.18

+3.68%

REGN

4.21

773.94

-0.84%

MRK

4.20

106.06

-0.53%

MLTX

3.50

13.21

-3.54%

INSM Price Performance

$206.78 (-15.81%)

$158.28 (+9.99%)

$109.55 (+58.91%)

$72.75 (+139.30%)

1year

6month

3month

1month

INSM Analysts Opinion

INSM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

INSM Analysts Opinion

INSM Analysts opinion is positive and also has improved from the past 3 months

INSM Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

60%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

13%

75%

INSM Street Sentiment

INSM Street Sentiment is bullish and have positive views on the near-term outlook

INSM Risk Level

INSM has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Fair

LOW

HIGH

INSM Performance Sentiment

Sentiments overview associated with INSM events and the stock performance.

60%

32%

Positive

Negative

15 out of 25
events present

8 out of 25
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$174.09

Resistance
Price

$159.93

Current Price Range

$206.78

Show methods +

INSM Stock IQ

Login to unlock Insmed (INSM) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

INSM Latest Analysis

A Closer Look at Insmeds Options Market Dynamics. High-rolling investors have positioned themselves bearish on Insmed (NASDAQ:INSM) and it'.s important for retail traders to take note.\This activity came to our attention today through Benzinga'.s tracking of publicly available options data. The identities of these investors are uncertain but such a significant move in INSM often signals that someone has privileged information.Today Benzinga'.s options scanner spotted 8 options trades

Fri Dec 26, 2025

$177.88 | +0.26%

Momentum

Potential

HC Wainwright & Co. Maintains Insmed (INSM) Buy Recommendation. Fintel reports that on December 18 2025 HC Wainwright &. Co. maintained coverage of Insmed (NasdaqGS:INSM) with a Buy recommendation. Analyst Price Forecast Suggests 30.50% Upside

Fri Dec 19, 2025

$174.84 | +4.98%

Rating

Goldman Sachs Maintains Insmed (INSM) Buy Recommendation. Fintel reports that on December 18 2025 Goldman Sachs maintained coverage of Insmed (NasdaqGS:INSM) with a Buy recommendation. Analyst Price Forecast Suggests 30.50% Upside

Fri Dec 19, 2025

$174.84 | +4.98%

Rating

TD Cowen Maintains Insmed (INSM) Buy Recommendation. Fintel reports that on December 18 2025 TD Cowen maintained coverage of Insmed (NasdaqGS:INSM) with a Buy recommendation. Analyst Price Forecast Suggests 30.50% Upside

Fri Dec 19, 2025

$174.84 | +4.98%

Rating

RBC Capital Maintains Insmed (INSM) Outperform Recommendation. Fintel reports that on December 18 2025 RBC Capital maintained coverage of Insmed (NasdaqGS:INSM) with a Outperform recommendation. Analyst Price Forecast Suggests 30.50% Upside

Fri Dec 19, 2025

$174.84 | +4.98%

Potential

Rating

Guggenheim Maintains Insmed (INSM) Buy Recommendation. Fintel reports that on December 18 2025 Guggenheim maintained coverage of Insmed (NasdaqGS:INSM) with a Buy recommendation. Analyst Price Forecast Suggests 30.50% Upside

Fri Dec 19, 2025

$174.84 | +4.98%

Rating

Noteworthy Thursday Option Activity: INSM MDB HEI. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Insmed Inc (Symbol: INSM) where a total volume of 13421 contracts has been traded thus far today a contract volume which is representative of approximately 1.

Thu Dec 18, 2025

$166.55 | -16.08%

Momentum

Why Is Insmed Stock Falling Thursday?. INSM) stock plunged on Thursday.The company released data from the Phase 2b BiRCh study of brensocatib in patients with chronic rhinosinusitis .The trial did not meet its primary or secondary efficacy endpoints in either the 10 mg or .Brensocatib was well tolerated with no new safety signals identified including in the 40 mg arm which is the highest dose Insmed has studied to date.Insmed has discontinued its development program of brensocatib in CRSsNP effe

Thu Dec 18, 2025

$166.55 | -16.08%

Momentum

Insmed is Now Oversold (INSM). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

Thu Dec 18, 2025

$166.55 | -16.08%

Technical

INSM Stock Plummets on Sinus Study Failure Adds New Pipeline Asset. Insmed sinks nearly 20% after Brinsupri failed a phase IIb sinus study while the company adds a new monoclonal antibody asset to expand its pipeline.

Thu Dec 18, 2025

$166.55 | -16.08%

Activity

Discover INSM Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of INSM. We're here to help you make informed investment decisions today.

FIND US ON

Receive our INSM Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

INSM Stock trends

INSM Stock performance

INSM Stock analysis

INSM investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing INSM

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing INSM

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

INSM Stock Analysis & IQ Rating | Insmed

BQ Stock IQ

INSM Target Price

INSM Risk Level

INSM Analysts Opinion

INSM Street Sentiment

INSM Performance Sentiment

Technical Price Levels

Explore our INSM Stock insights

Receive our INSM Daily Alerts

INSM Street Sentiment

INSM Risk Level

Technical Price Levels

Discover INSM Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of INSM. We're here to help you make informed investment decisions today.

Receive our INSM Daily Alerts

INSM Alerts